Type |
Details |
Score |
Protein Domain |
Type: |
Domain |
Description: |
The SARAH (Sav/Rassf/Hpo) domain is found at the C terminus in three classes of eukaryotic tumour suppressors that give the domain its name. In the Sav (Salvador) and Hpo (Hippo) families, the SARAH domain mediates signal transduction from Hpo via the Sav scaffolding protein to the downstream component Wts (Warts); the phosphorylation of Wts by Hpo triggers cell cycle arrest and apoptosis by down-regulating cyclin E, Diap 1 and other targets [, ]. The SARAH domain is also involved in dimerisation, as in the human Hpo orthologue, Mst1, which homodimerises via its C-terminal SARAH domain. The SARAH domain is found associated with other domains, such as protein kinase domains, WW/rsp5/WWP domain (), C1 domain (), LIM domain (), or the Ras-associating (RA) domain ().This entry represents the C-terminal SARAH domain of Mst1. The Mst1 SARAH domain interacts with Rassf1 and Rassf5 by forming a heterodimer which mediates the apoptosis process []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
487
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Li C |
Year: |
2017 |
Journal: |
Nat Commun |
Title: |
Dendritic cell MST1 inhibits Th17 differentiation. |
Volume: |
8 |
|
Pages: |
14275 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schirone L |
Year: |
2023 |
Journal: |
Cell Mol Life Sci |
Title: |
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation. |
Volume: |
80 |
Issue: |
9 |
Pages: |
245 |
|
•
•
•
•
•
|
Publication |
First Author: |
Scheel H |
Year: |
2003 |
Journal: |
Curr Biol |
Title: |
A novel interaction motif, SARAH, connects three classes of tumor suppressor. |
Volume: |
13 |
Issue: |
23 |
Pages: |
R899-900 |
|
•
•
•
•
•
|
Pathway |
|
•
•
•
•
•
|
Publication |
First Author: |
Meng F |
Year: |
2016 |
Journal: |
Genes Dev |
Title: |
Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation. |
Volume: |
30 |
Issue: |
9 |
Pages: |
1086-100 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee IY |
Year: |
2019 |
Journal: |
Mol Cell |
Title: |
MST1 Negatively Regulates TNFα-Induced NF-κB Signaling through Modulating LUBAC Activity. |
Volume: |
73 |
Issue: |
6 |
Pages: |
1138-1149.e6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bagherzadeh Yazdchi S |
Year: |
2019 |
Journal: |
J Immunol |
Title: |
Hippo Pathway Kinase Mst1 Is Required for Long-Lived Humoral Immunity. |
Volume: |
202 |
Issue: |
1 |
Pages: |
69-78 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shang X |
Year: |
2020 |
Journal: |
J Cell Physiol |
Title: |
Mst1 deletion reduces septic cardiomyopathy via activating Parkin-related mitophagy. |
Volume: |
235 |
Issue: |
1 |
Pages: |
317-327 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fukuhara T |
Year: |
2015 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Hypermethylation of MST1 in IgG4-related autoimmune pancreatitis and rheumatoid arthritis. |
Volume: |
463 |
Issue: |
4 |
Pages: |
968-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin Y |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis. |
Volume: |
277 |
Issue: |
50 |
Pages: |
47991-8001 |
|
•
•
•
•
•
|
Publication |
First Author: |
Glantschnig H |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. |
Volume: |
277 |
Issue: |
45 |
Pages: |
42987-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee KK |
Year: |
2000 |
Journal: |
GenBank Submission |
Title: |
Mus musculus STE20-like kinase MST1 mRNA, complete cds |
|
|
Pages: |
AF271360 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yasuda K |
Year: |
2016 |
Journal: |
FEBS Lett |
Title: |
Enhanced cytotoxic T-cell function and inhibition of tumor progression by Mst1 deficiency. |
Volume: |
590 |
Issue: |
1 |
Pages: |
68-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Du X |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Mst1 and mst2 are essential regulators of trophoblast differentiation and placenta morphogenesis. |
Volume: |
9 |
Issue: |
3 |
Pages: |
e90701 |
|
•
•
•
•
•
|
Publication |
First Author: |
Song H |
Year: |
2010 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity. |
Volume: |
391 |
Issue: |
1 |
Pages: |
969-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Geng J |
Year: |
2015 |
Journal: |
Nat Immunol |
Title: |
Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. |
Volume: |
16 |
Issue: |
11 |
Pages: |
1142-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fan F |
Year: |
2016 |
Journal: |
Sci Transl Med |
Title: |
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. |
Volume: |
8 |
Issue: |
352 |
Pages: |
352ra108 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tomiyama T |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Antigen-specific suppression and immunological synapse formation by regulatory T cells require the Mst1 kinase. |
Volume: |
8 |
Issue: |
9 |
Pages: |
e73874 |
|
•
•
•
•
•
|
Publication |
First Author: |
Song H |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. |
Volume: |
107 |
Issue: |
4 |
Pages: |
1431-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamamoto S |
Year: |
2003 |
Journal: |
J Clin Invest |
Title: |
Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. |
Volume: |
111 |
Issue: |
10 |
Pages: |
1463-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee SJ |
Year: |
2014 |
Journal: |
Glia |
Title: |
The role of reciprocal activation of cAbl and Mst1 in the oxidative death of cultured astrocytes. |
Volume: |
62 |
Issue: |
4 |
Pages: |
639-48 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ardestani A |
Year: |
2014 |
Journal: |
Nat Med |
Title: |
MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes. |
Volume: |
20 |
Issue: |
4 |
Pages: |
385-397 |
|
•
•
•
•
•
|
Publication |
First Author: |
Oh S |
Year: |
2009 |
Journal: |
Mol Cell Biol |
Title: |
Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. |
Volume: |
29 |
Issue: |
23 |
Pages: |
6309-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xiong Z |
Year: |
2020 |
Journal: |
Biochim Biophys Acta Mol Basis Dis |
Title: |
Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice. |
Volume: |
1866 |
Issue: |
8 |
Pages: |
165806 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morinaka A |
Year: |
2011 |
Journal: |
Oncogene |
Title: |
Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis. |
Volume: |
30 |
Issue: |
40 |
Pages: |
4208-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Oh HJ |
Year: |
2010 |
Journal: |
Curr Biol |
Title: |
MST1 limits the kinase activity of aurora B to promote stable kinetochore-microtubule attachment. |
Volume: |
20 |
Issue: |
5 |
Pages: |
416-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu J |
Year: |
2016 |
Journal: |
J Cell Mol Med |
Title: |
Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibition. |
Volume: |
20 |
Issue: |
1 |
Pages: |
147-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin J |
Year: |
2016 |
Journal: |
Sci Rep |
Title: |
Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunction. |
Volume: |
6 |
|
Pages: |
34199 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu J |
Year: |
2018 |
Journal: |
Biochim Biophys Acta Mol Basis Dis |
Title: |
Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy. |
Volume: |
1864 |
Issue: |
11 |
Pages: |
3639-3649 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cheng Z |
Year: |
2019 |
Journal: |
J Cell Mol Med |
Title: |
Cardiac-specific Mst1 deficiency inhibits ROS-mediated JNK signalling to alleviate Ang II-induced cardiomyocyte apoptosis. |
Volume: |
23 |
Issue: |
1 |
Pages: |
543-555 |
|
•
•
•
•
•
|
Publication |
First Author: |
Feng X |
Year: |
2020 |
Journal: |
Front Cell Dev Biol |
Title: |
Mst1 Knockout Alleviates Mitochondrial Fission and Mitigates Left Ventricular Remodeling in the Development of Diabetic Cardiomyopathy. |
Volume: |
8 |
|
Pages: |
628842 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nguyen MN |
Year: |
2019 |
Journal: |
Am J Physiol Heart Circ Physiol |
Title: |
Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling. |
Volume: |
316 |
Issue: |
1 |
Pages: |
H45-H60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee GJ |
Year: |
2015 |
Journal: |
Basic Res Cardiol |
Title: |
Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis. |
Volume: |
110 |
Issue: |
2 |
Pages: |
7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shi H |
Year: |
2018 |
Journal: |
Immunity |
Title: |
Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity. |
Volume: |
49 |
Issue: |
5 |
Pages: |
899-914.e6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou D |
Year: |
2009 |
Journal: |
Cancer Cell |
Title: |
Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. |
Volume: |
16 |
Issue: |
5 |
Pages: |
425-38 |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
126
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Cairns L |
Year: |
2018 |
Journal: |
J Biol Chem |
Title: |
Salvador has an extended SARAH domain that mediates binding to Hippo kinase. |
Volume: |
293 |
Issue: |
15 |
Pages: |
5532-5543 |
|
•
•
•
•
•
|
Allele |
Name: |
macrophage stimulating 1 (hepatocyte growth factor-like); endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Publication |
First Author: |
Cheng Z |
Year: |
2018 |
Journal: |
J Mol Cell Cardiol |
Title: |
Mst1 knockout enhances cardiomyocyte autophagic flux to alleviate angiotensin II-induced cardiac injury independent of angiotensin II receptors. |
Volume: |
125 |
|
Pages: |
117-128 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
716
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou D |
Year: |
2011 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. |
Volume: |
108 |
Issue: |
49 |
Pages: |
E1312-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Meng C |
Year: |
2020 |
Journal: |
Cell Death Differ |
Title: |
Hippo kinases MST1 and MST2 control the differentiation of the epididymal initial segment via the MEK-ERK pathway. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Tang F |
Year: |
2015 |
Journal: |
Sci Signal |
Title: |
The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motility. |
Volume: |
8 |
Issue: |
397 |
Pages: |
ra100 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1378
|
Fragment?: |
false |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling. |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
321
|
Fragment?: |
true |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
436
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
507
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
252
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
497
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
495
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Cinar B |
Year: |
2007 |
Journal: |
EMBO J |
Title: |
The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. |
Volume: |
26 |
Issue: |
21 |
Pages: |
4523-34 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
E-GEOD-61582 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry includes hepatocyte growth factor (HGF; also called scatter factor) and HGF-like proteins (also known as macrophage stimulatory protein, MST1). Hepatocyte growth factor (HGF) is an activating ligand of the Met receptor tyrosine kinase, whose activity is essential for normal tissue development and organ regeneration []. HGF is essential for placental, liver, and muscle development, whereas MST1 is not required for embryogenesis, fertility, or wound healing. Genes for HGF and its receptor, the Met tyrosine kinase, are close together on chromosome 7, so that polysomy of chromosome 7 may contribute to malignancy through overproduction of both molecules. MST1 and its receptor, the Ron tyrosine kinase, are close together on chromosome 3. HGF and MST1 are closely related to plasminogen, having similar domain architecture: signal sequence followed by a PAN (formerly apple) domain, four (rather than five) kringle domains, and a trypsin domain, which appears to lack any peptidase activity. |
|
•
•
•
•
•
|
Publication |
First Author: |
Tolbert WD |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Structural basis for agonism and antagonism of hepatocyte growth factor. |
Volume: |
107 |
Issue: |
30 |
Pages: |
13264-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao B |
Year: |
2009 |
Journal: |
Cancer Cell |
Title: |
Mst out and HCC in. |
Volume: |
16 |
Issue: |
5 |
Pages: |
363-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Melum E |
Year: |
2011 |
Journal: |
Nat Genet |
Title: |
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. |
Volume: |
43 |
Issue: |
1 |
Pages: |
17-9 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE73911 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee JH |
Year: |
2008 |
Journal: |
EMBO J |
Title: |
A crucial role of WW45 in developing epithelial tissues in the mouse. |
Volume: |
27 |
Issue: |
8 |
Pages: |
1231-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Raynor JL |
Year: |
2020 |
Journal: |
J Exp Med |
Title: |
Hippo/Mst signaling coordinates cellular quiescence with terminal maturation in iNKT cell development and fate decisions. |
Volume: |
217 |
Issue: |
6 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Li W |
Year: |
2019 |
Journal: |
Cell Death Differ |
Title: |
Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation. |
Volume: |
26 |
Issue: |
8 |
Pages: |
1379-1395 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim YH |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
A MST1-FOXO1 cascade establishes endothelial tip cell polarity and facilitates sprouting angiogenesis. |
Volume: |
10 |
Issue: |
1 |
Pages: |
838 |
|
•
•
•
•
•
|
Publication |
First Author: |
Manderfield LJ |
Year: |
2014 |
Journal: |
Cell Rep |
Title: |
Pax3 and hippo signaling coordinate melanocyte gene expression in neural crest. |
Volume: |
9 |
Issue: |
5 |
Pages: |
1885-1895 |
|
•
•
•
•
•
|
Publication |
First Author: |
Anguera MC |
Year: |
2008 |
Journal: |
Dev Dyn |
Title: |
Characterization of two Mst1-deficient mouse models. |
Volume: |
237 |
Issue: |
11 |
Pages: |
3424-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang P |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis. |
Volume: |
10 |
Issue: |
1 |
Pages: |
755 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee DH |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
Mammalian sterile 20 kinase 1 and 2 are important regulators of hematopoietic stem cells in stress condition. |
Volume: |
8 |
Issue: |
1 |
Pages: |
942 |
|
•
•
•
•
•
|
Publication |
First Author: |
Raab M |
Year: |
2010 |
Journal: |
Immunity |
Title: |
T cell receptor "inside-out" pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes. |
Volume: |
32 |
Issue: |
4 |
Pages: |
541-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ardestani A |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Neratinib protects pancreatic beta cells in diabetes. |
Volume: |
10 |
Issue: |
1 |
Pages: |
5015 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yao HP |
Year: |
2013 |
Journal: |
Nat Rev Cancer |
Title: |
MSP-RON signalling in cancer: pathogenesis and therapeutic potential. |
Volume: |
13 |
Issue: |
7 |
Pages: |
466-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bae SJ |
Year: |
2015 |
Journal: |
Nat Commun |
Title: |
NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway. |
Volume: |
6 |
|
Pages: |
6314 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liang Y |
Year: |
2022 |
Journal: |
Bioengineered |
Title: |
Knockout of circRNA single stranded interacting protein 1 (circRBMS1) played a protective role in myocardial ischemia-reperfusion injury though inhibition of miR-2355-3p/Mammalian Sterile20-like kinase 1 (MST1) axis. |
Volume: |
13 |
Issue: |
5 |
Pages: |
12726-12737 |
|
•
•
•
•
•
|
Publication |
First Author: |
Khokhlatchev A |
Year: |
2002 |
Journal: |
Curr Biol |
Title: |
Identification of a novel Ras-regulated proapoptotic pathway. |
Volume: |
12 |
Issue: |
4 |
Pages: |
253-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou Y |
Year: |
2011 |
Journal: |
Mol Cell Biol |
Title: |
MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosis. |
Volume: |
31 |
Issue: |
17 |
Pages: |
3603-15 |
|
•
•
•
•
•
|
Publication |
First Author: |
Johnston AM |
Year: |
2000 |
Journal: |
Oncogene |
Title: |
SPAK, a STE20/SPS1-related kinase that activates the p38 pathway. |
Volume: |
19 |
Issue: |
37 |
Pages: |
4290-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee KK |
Year: |
2001 |
Journal: |
J Biol Chem |
Title: |
MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. |
Volume: |
276 |
Issue: |
22 |
Pages: |
19276-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Park J |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
Tumor suppressor ras association domain family 5 (RASSF5/NORE1) mediates death receptor ligand-induced apoptosis. |
Volume: |
285 |
Issue: |
45 |
Pages: |
35029-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cornils H |
Year: |
2010 |
Journal: |
Sci Signal |
Title: |
Ablation of the kinase NDR1 predisposes mice to the development of T cell lymphoma. |
Volume: |
3 |
Issue: |
126 |
Pages: |
ra47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ishihara S |
Year: |
2020 |
Journal: |
BMC Biol |
Title: |
Phosphatidic acid-dependent localization and basal de-phosphorylation of RA-GEFs regulate lymphocyte trafficking. |
Volume: |
18 |
Issue: |
1 |
Pages: |
75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gao T |
Year: |
2013 |
Journal: |
Gastroenterology |
Title: |
Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. |
Volume: |
144 |
Issue: |
7 |
Pages: |
1543-53, 1553.e1 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lange AW |
Year: |
2015 |
Journal: |
J Mol Cell Biol |
Title: |
Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung. |
Volume: |
7 |
Issue: |
1 |
Pages: |
35-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo C |
Year: |
2007 |
Journal: |
Curr Biol |
Title: |
RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. |
Volume: |
17 |
Issue: |
8 |
Pages: |
700-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang X |
Year: |
2016 |
Journal: |
Cancer Res |
Title: |
Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1. |
Volume: |
76 |
Issue: |
9 |
Pages: |
2824-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Del Re DP |
Year: |
2010 |
Journal: |
J Clin Invest |
Title: |
Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. |
Volume: |
120 |
Issue: |
10 |
Pages: |
3555-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zou J |
Year: |
2018 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Neddylation mediates ventricular chamber maturation through repression of Hippo signaling. |
Volume: |
115 |
Issue: |
17 |
Pages: |
E4101-E4110 |
|
•
•
•
•
•
|
Publication |
First Author: |
Du X |
Year: |
2014 |
Journal: |
J Immunol |
Title: |
Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. |
Volume: |
192 |
Issue: |
4 |
Pages: |
1525-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mueller KA |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
Hippo Signaling Pathway Dysregulation in Human Huntington's Disease Brain and Neuronal Stem Cells. |
Volume: |
8 |
Issue: |
1 |
Pages: |
11355 |
|
•
•
•
•
•
|
Publication |
First Author: |
Babicky ML |
Year: |
2019 |
Journal: |
Oncogene |
Title: |
MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages. |
Volume: |
38 |
Issue: |
28 |
Pages: |
5599-5611 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim W |
Year: |
2017 |
Journal: |
J Clin Invest |
Title: |
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis. |
Volume: |
127 |
Issue: |
1 |
Pages: |
137-152 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stoner SA |
Year: |
2019 |
Journal: |
Blood |
Title: |
Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation. |
Volume: |
134 |
Issue: |
20 |
Pages: |
1730-1744 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wei B |
Year: |
2013 |
Journal: |
BMC Biol |
Title: |
MST1, a key player, in enhancing fast skeletal muscle atrophy. |
Volume: |
11 |
|
Pages: |
12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chu PY |
Year: |
2010 |
Journal: |
Am J Pathol |
Title: |
Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. |
Volume: |
176 |
Issue: |
4 |
Pages: |
1735-42 |
|
•
•
•
•
•
|